Few direct APE1 catalytic small molecule inhibitors have also been developed and are shown to sensitize other cancer cell lines when used in combination with chemotherapeutics, methylmethanesulfonate (MMS), and temozolomide (TMZ) [178,179,180]. Here, APEX1 is linked to cancer.